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 Abstract  
Objectives: Cognitive-behavioral therapies (CBT) for fibromyalgia (FMS) are   important 
interventions in the management of this condition. Empirical evidence reports that although the 
results are promising, further research is needed to respond more appropriately to these patients. 
This study focuses on exploring the use of Virtual Reality (VR) as an adjunct to the activity 
management component. The aim of this study is to present the results of a small-sized 
randomized controlled trial to test the preliminary efficacy and acceptability of this component.  
Methods: The final sample was composed of 61 women diagnosed with FMS according to the 
American College of Rheumatology. The sample was randomly allocated to two conditions: VR 
treatment and treatment as usual.  
Results: Participants in the VR condition achieved significant improvements in the primary 
outcome: disability measured with the FIQ. The improvement was also significant in secondary 
outcomes, such as perceived quality of life and some of the coping strategies included in the 
CPCI: Task persistence, and Exercise. There were no differences in other secondary outcome 
measures like pain intensity and interference and depression. Participants reported high 
satisfaction with the VR component.  
Discussion: The effects were related to the psychological aspects targeted in the treatment. The 
component was well-accepted by FMS patients referred from a public hospital. These findings 
show that the VR component could be useful in the CBT treatment of FMS and encourage us to 
continue exploring the use of integrating VR with CBT interventions for the treatment of FMS. 
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Introduction  
Fibromyalgia syndrome (FMS) is a chronic musculoskeletal pain condition [1], 
characterized by widespread pain accompanied by fatigue and disturbed sleep and mood [2] 
affecting around 2 to 4% of the general population. [3] Comorbidities with affective and anxiety 
disorders are common [4] and it is associated with frequent medical consultation and work 
disability, resulting in high economic and social burden. [5] 
The scientific literature supports the conceptualization of this condition in an integrative 
biopsychosocial model that includes physiological, psychological, and social aspects. [6] The 
treatment of FMS has a poor prognosis for recovery [7] and it is considered a challenge for 
health professionals. Addressing FMS from a multidimensional perspective seems to be more 
effective than from single approaches. [8] 
The multidimensional perspective includes psychological programs as a promising 
treatment for FMS. Psychological aspects such as self-efficacy, attention, appraisal of pain, or 
avoidance are among the best predictors of disability caused by chronic pain. [9] There are 
several studies testing the efficacy of psychological programs for FMS. In an excellent meta-
analysis, [10] 23 studies involving 1.396 patients were reviewed. The results revealed that the 
effect sizes of short- and long-term efficacy for psychological treatments were small yet robust. 
Cognitive Behavioral Therapy (CBT) was associated with the greatest effect sizes. The authors 
concluded that psychological programs are promising interventions for FMS. However, they 
noted that there are still relatively few studies on psychological treatments for FMS, and they 
recommended carrying out more efficacy studies. Another finding is that although the results are 
promising, there is still room for improvement given that effect sizes are only small or moderate. 
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In summary, efficacy is still limited and further research is needed to respond more appropriately 
to patients with FMS.  
Among the possible ways of improving psychological treatments in this field, an 
attractive line of research is the use of technology to support the interventions. One of the most 
promising technologies is Virtual Reality (VR). Its use in the field of psychology has increased 
in recent years. VR has been shown to be a useful tool in the treatment of several psychological 
disorders. [11; 12] In the field of pain, VR has been used mainly as a distraction strategy for 
treating acute pain associated with medical procedures (e.g. wound care, physical therapy). 
Pioneer work in this field was conducted by Dr. Hoffman’s team at the University of Washington 
in studies that demonstrated the efficacy of VR for burn patients. [13] A systematic review about 
the use of VR distraction for pain reduction found promising results for the efficacy of this 
procedure. [14] Another use of VR in the treatment of acute pain is in combination with 
hypnosis. Patterson and his team [15; 16] were the pioneers in this approach, finding important 
reduction in pain in burn patients. 
When we look at the literature on the applications of VR in the field of chronic pain we 
see it is very scarce. Keefe et al. [17] have reviewed this issue and have found some preliminary 
studies focusing on VR for pain-related movement patterns and in combination with other 
psychological strategies. The idea is that VR could be a good tool to expose patients to 
movements that they may fear or avoid due to pain. It has been suggested that mirrors and VR 
could be potential new treatments for this condition. [18] A similar VR application has also been 
used to reduce phantom limb pain in amputees [19; 20; 21] and in complex regional pain 
syndrome (CRPS). [22; 23] Gromala et al.  [24] have developed a virtual walk that includes 
audio and visual feedback to induce relaxation while walking. There are some preliminary 
Copyright © 2014 Wolters Kluwer Health, Inc. Unauthorized reproduction of the article is prohibited.
studies exploring the combination of VR with other interventions for persistent pain, such as a 
case study using VR hypnosis for neuropathic pain [25], a study protocol for the use of VR in 
combination with exposure to the treatment of pain catastrophizing in FMS [26] and VR as a 
distraction technique in chronic pain patients [27]. Our research group has explored the use of 
VR in combination with mindfulness and relaxation in a sample of six FMS patients. [28] 
Keefe et al. [17] indicated some advantages of integrating VR with behavioral 
interventions for pain, like the potential of VR for standardizing the presentation of therapeutic 
instructions or the use of VR for patients who fail to respond to conventional interventions. They 
also mentioned the idea that once the patients have gained pain control via an integrated 
VR/behavioral intervention, they may be more motivated with practicing the strategies in their 
natural environment. We believe this is one of the best features of VR in the field of chronic 
pain. Keefe et al. finished their review encouraging researchers to be active in conducting studies 
exploring the possibilities of VR in chronic pain. In the present study, we explore the 
combination of VR with activity management. 
Activity management is one of the most used treatment components in psychological 
programs for chronic pain. [29] An important goal for chronic pain patients is to balance rest and 
activity. However, this is a big challenge. First, patients have problems with pacing activity. 
After periods of restricted activity to diminish pain, patients may feel better, and then increase 
activity. This higher activity increases pain, and causes another period of inactivity, and this 
continues in a cyclical way. Unfortunately, what chronic pain patients learn from this pattern is 
to avoid activity. Second, patients with chronic pain attempt to protect and not use the parts of 
their body that hurt, which leads to an additional deactivation and muscle weakness. To address 
these problems the challenge is to identify the activities that the patient avoids, and to increase 
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contact with valued activities. This can be achieved with activity management. This component 
consists of setting goals related to activities that are meaningful for the patient and progressively 
perform those activities balancing the periods of rest and activity. Feelings like low mood and 
fear, and the symptoms of the condition – pain, and more importantly, fatigue – get in the way of 
the willingness to perform the activities, causing low motivation and a poor sense of self-
efficacy. An important goal is to promote motivation. The promotion of positive emotions can 
help to increase motivation towards activity. There is a line of research studying positive affect 
and their influences on cognitive processes, well-being and health, [30, 31] which offers 
evidence supporting the idea that positive affect promote flexible and creative thinking and play 
a main role in building psychological strength, and intellectual and social resources. [32] The 
promotion of positive emotions has several applications in the field of psychological treatments. 
For example, positive emotions have the ability to alter or reduce the effects of negative 
emotions; therefore promotion of positive affect may help in the regulation of negative emotions. 
Also, if positive affect promote the increase of available resources, its promotion might help to 
maintain long-term gains and provide people with strength to become more resilient. Our 
research team is working in the study of the effect of positive affect in the treatment of mental 
and health problems and in the use of technology to promote well-being (positive technology). 
[33] 
The VR component developed is aimed to make it easier for the patients to start and 
maintain an activity management program. Using a VR adaptive display we developed contents 
to motivate FMS sufferers to get involved in the activity management component. The aim of 
this study is to show the results of a small-sized randomized trial testing the efficacy and 
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acceptability of the combination of VR with activity management. To our knowledge, this is the 
first study to test the use of VR in the field of chronic pain in a controlled study.  
 
Materials and Methods 
Design 
 A single-blind randomized controlled trial with repeated measures (pretreatment and 
posttreatment) and two conditions: VR activity management (VRAM) and treatment as usual 
(TAU). Missing data due to drop out were addressed using the last observation carried forward 
(LOCF) method. 
Participants 
Participants were recruited from the Rheumatology Service of a public hospital (Hospital 
General de Castellon, Spain). Some inclusion criteria were established – participants were 
required to: 1) have been diagnosed with FMS by a rheumatologist and in accordance with the 
American College of Rheumatology criteria; [1] 2) be 18-70 years old; 3) not be suffering from 
severe mental disorders such as schizophrenia, bipolar disorder, mental retardation, substance 
abuse or dependence, nor a mental disorder in need of immediate treatment (i.e. severe major 
depressive disorder); 4) not be suffering from a physical disease that could interfere with 
receiving a psychological treatment; and 5) not be in the process of requesting or suing for 
disability. 
This research belongs to a funded project approved by an ethical review board. 
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Ninety-five participants were eligible, but 34 were not allocated to the conditions for 
several reasons (see flow diagram in Figure 1). The main reason for the nine dropouts before 
allocation was that the participants found that if they would be allocated to the VRAM condition, 
the treatment sessions involved too much time (twice a week) and they were not ready to commit 
to it. The final sample comprised 61 Caucasian women with a diagnosis of FMS. The mean age 
of the sample was 50.48 years old (SD = 9.78), ranging from 23 to 70, and the mean duration of 
the FMS diagnosis was 9.32 years (SD = 8.15). All participants agreed to participate in the study 
and signed an informed consent form. One participant dropped out from the VRAM condition 
because she did not find the treatment helpful. One participant dropped out from the TAU 
condition. She did not attend a programmed visit with the rheumatologist and did not give any 
reason for not showing up. She did not contact the rheumatology service to reschedule another 
visit. 
- Figure 1 to be inserted here- 
Most participants were married (78.7%), 9.8% were single, 9.9 divorced and 1.6 widow. 
Regarding education, 21.3% had less than eight years of education, 36.1% had an elementary 
level of education (eight years), 31.2% had completed high school, and 11.4% had a university 
degree. As for occupation, 49.2% were housewives, 47.5% were employed outside of the home, 
and 3.3% were unemployed. Although 90% of the sample had a history of mood or anxiety 
disorders, only one patient had previously received psychological treatment. At the time of 
entering the study the participants’ mood or anxiety disorders were in remission (they did not 
meet DSM-IV-TR criteria for any mood or anxiety disorders) as established by a structured 
diagnostic interview (SCID-I). [34] Most patients (49.2%) were taking stable doses of painkillers 
such as paracetamol or non-steroidal anti-inflammatory drugs (NSAIDs). Forty-one percent were 
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receiving stable doses of pregabalin and 9.8% were not taking any medication. Patients in the 
VR treatment condition were told not to change the type of medication they were taking or to 
increase dosages while participating in the study unless instructed by a rheumatologist. None of 
them made medication alterations for the duration of the study. 
Primary outcome variable 
Disability 
Fibromyalgia Impact Questionnaire: [35; 36]: This is the most used self-report in the field 
of FMS. It assesses physical functioning, work status, depression, anxiety, sleep, pain, stiffness, 
fatigue, morning tiredness and well-being in patients with FMS. The FIQ is composed of ten 
questions, with each question rated on a four-point Likert-type scale. This instrument has 
demonstrated good psychometric properties across cultures and languages, including Spanish. 
Secondary outcome variables 
Pain intensity and interference  
The Brief Pain Inventory (BPI): [37; 38] This instrument assesses the severity of pain and 
the impact of pain on daily functions. The BPI has demonstrated both reliability and validity 
across cultures and languages, including Spanish, and has been widely used for clinical pain 
assessment. It contains 11 items: the first four items refer to pain intensity and the following 
seven items relate to pain interference with activities.   
 Coping  
Chronic Pain Coping Inventory (CPCI): [39] This instrument identifies coping strategies 
that patients use to deal with chronic pain. It is a 64-item measure that was designed to assess 
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coping subscales that fall into three categories: illness-focused coping (Guarding, Resting, and 
Asking for Assistance), wellness-focused coping (Relaxation, Task Persistence, Exercise/Stretch, 
and Coping Self-Statements), and neutral coping (Seeking Social Support subscale). Subscales 
demonstrate adequate to good internal consistency and validity.  
Mood 
Beck Depression Inventory II (BDI-II): [40; 41] This is one of the most used self-report 
instruments to assess depression. It presents good psychometric properties in the English and 
Spanish versions. This inventory includes 21 items evaluating cognitive, behavioral, affective 
and somatic symptoms of depression. A score from 0 to 13 indicates minimal depression, from 
14 to 19 mild depression, from 20 to 28 moderate depression, and from 29 to 63 severe 
depression. 
Perceived quality of life 
The Quality of Life Index (QLI-Sp) [42] is a self-report questionnaire that measures 
perceived health-related quality of life that includes 10 items or domains: physical well-being, 
psychological/emotional well-being, self-care and independent functioning, occupational 
functioning, interpersonal functioning, social-emotional support, community and services 
support, personal fulfillment, spiritual fulfillment, and overall quality of life.  
Acceptability and satisfaction 
Given that VR is a new element in the treatment of chronic pain we were interested in 
having the participants’ opinion about it in order to assess satisfaction and acceptability. We used 
a scale (satisfaction and acceptability scale), adapted from Borkovec and Nau, [43] to measure 
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satisfaction with the treatment program and with the VR component only after completion of the 
treatment. Participants were asked several questions about their satisfaction and acceptability 
regarding the treatment program and the VR component (in the results section the specific 
questions are displayed). The participants rated the items on a 0 to 10 scale where 0 was “not at 
all” and 10 was “completely.”  
Treatment 
The treatment was a group CBT program for FMS supported by VR as an adjunct to the 
activity pacing component. The treatment was designed according to the guidelines of existing 
CBT programs. [29] The aim of this study was to test the acceptability and preliminary efficacy 
of the activity management component supported by VR. Because of that we only included the 
activity management component as the key ingredient of the program, and we did not include 
other useful components like cognitive therapy or relaxation. The program included six two-hour 
group sessions delivered twice a week. The session format was as follows: 1) Overview of the 
last session and introduction of agenda; 2) Homework review; 3) Specific content of session; 4) 
Homework assignment. 
The treatment program included the following components:  
1) Education about chronic pain and FMS: Participants were given descriptions of the 
biopsychological model of chronic pain and FMS, the psychological, biological and social 
factors influencing the experience of pain and other symptoms, and the rationale of the CBT 
program for the treatment of FMS. This component was administered in the first session. 
2) Activity management: Participants were provided with the rationale for activity pacing 
(balancing activity with periods of rest by means of meaningful programmed activities in order 
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to achieve a healthy level of activity, promoting self-efficacy, and decreasing negative affect and 
avoidance of activities because of pain). This component was administered from session 2 to 6 
and was supported by a VR environment that was displayed on a big screen. The aim of this 
component was to use multimedia elements to enhance motivation and positive affect related to 
the performing of meaningful activities (see more detailed description in the section describing 
the virtual environment). 
3) Relapse prevention: Participants were offered an overview of the program to help 
solve their doubts and to answer their questions about the different strategies they had learned. 
They were also assisted in planning how to use the strategies in the future and were instructed on 
how to anticipate and confront high-risk situations. Relapse prevention was administered in the 
last hour of session 6. 
Participants in the TAU condition received the usual care in a rheumatology unit in a 
public setting in Spain that consists of follow-up sessions by a rheumatologist to review the 
medication treatment. All participants attended at least 1 session in the five weeks after the pre-
treatment assessment. 
Therapists 
Four therapists participated in the study. There were two therapists in each group. The 
role of the leading therapist was to apply the treatment. The role of the assistant therapist was to 
prepare all the materials needed for each session, run the VR equipment, and to support the 
therapist in applying the treatment. The leading therapists held a Ph.D. degree and had expertise 
in the delivery of CBT and VR therapy. The other two therapists acted as assistant therapists. 
They were PhD students and they had a master degree and training in CBT and VR therapy. 
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Virtual environment description 
The configuration used different devices: Two PC computers, a 3 x 4 m screen made of 
reflective material, two projectors (with a 1920x1080 pixel resolution, 2000 lumen power and 
50000:1 contrast) and a 7.1 surround audio system.  The PC1 has the graphical outputs from its 
graphic card connected to the projector, which are used to project the environment on a 
metacrilate screen. Specifically, the main characteristics of this PC1 are the following: a 2 Ghz 
Intel Pentium 4 processor, a 256 MB graphic card, 1 GB RAM, an Ethernet network card for 
connecting to the other PC. The operating system was Windows XP. 
The PC2 is the host of the therapist’s application and controls the features of the VR 
environment that is shown to the patient. The characteristics of this PC2 are the following: a 3 
Ghz Intel Pentium 4 processor, a Nvidia GeForce 7800 graphic card, 2 GB RAM, and a TFT 
screen. 
The characteristics of this VR environment configuration (using a large screen and not a head-
mounted display) allow VR sessions to be performed in groups. This is important in the case of 
FMS given that group therapy is recommended for chronic pain sufferers. [29] Participants were 
placed in front of the screen in groups of six. One of the therapists was in charge of operating the 
VR system during the VR session.  
The VR environment was an adaptive display named EMMA, developed in the framework of an 
EU-funded project (IST-2001-39192-EMMA, Engaging Media for Mental Health Applications). 
EMMA is a flexible VR environment that includes five predefined scenarios. These scenarios are 
aimed at promoting emotions and motivation, depending on the goal of the therapy session. The 
five scenarios are: a desert, a beach, a forest, a snowy landscape and a meadow. It is possible to 
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use different elements in these scenarios, such as changes in the weather or in the time (day and 
night), and to include sounds, images, and videos. This VR environment has demonstrated its 
capacity to induce several emotions [44], and it has been used for the treatment of stress-related 
disorders. [45; 46]. We conducted a study to test its capacity to test positive emotions in chronic 
pain patients. [47] 
In this study the scenarios chosen were the beach and the meadow. In addition, specific 
music, sounds, narratives and images were selected to encourage the occurrence of positive 
emotions and motivation in order to enhance self-efficacy and behavior activation. In Figures 2 
and 3 we display images of the setting and the VR environment.  
The music was selected following two methods. On the one hand, melodies were 
chosen following two rules of music structure: tempo and mode. [48; 49] A fast tempo evokes 
energy and activation, and a major mode is related with positive mood. [50; 51] On the other 
hand, resources from the International Affective Digitized Sounds (IADS) [52] were included 
that take into consideration the dimensions of emotional arousal and valence, [53; 54] and 
melodies with positive valence and high arousal were selected.  With regard to the images, they 
were selected from the International Affective Picture System (IAPS) [55; 56], also meeting the 
criteria of positive valence and high arousal. Other images from other sources were also 
included, and were selected according to three dimensions: color, brightness and saturation. 
Research indicates that positive emotions are evoked through bright and high-saturated color 
images. Also, there was a predominance of green and blue, colors that have been shown to 
induce positive emotions. [57] 
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In addition to images and sounds, we included narratives especially designed to 
promote motivation in FMS sufferers. The narratives were designed by a team of therapists with 
expertise in cognitive-behavior therapy and in the treatment of chronic pain.  
 With all these elements we designed three VR sessions that lasted around 20 minutes 
each. The use of VR was embedded in the activity management component. The content of the 
first VR session (VR1) included the rationale of the activity management and instructions to 
enhance motivation to start to perform meaningful activities. The second VR session (VR2) dealt 
with acknowledging and overcoming the barriers that prevent the performance of activities. 
Finally, the third VR session (VR3) included instructions to acknowledge personal strengths that 
could be used to motivate patients to get involved in meaningful activities. VR1 was used in 
session 2 of the program, VR2 was used in sessions 3 and 5, and VR3 was used in sessions 4 and 
6. 
- Figures 2 and 3 to be inserted here- 
Procedure  
The present study was conducted at Universitat Jaume I in Castellon, Spain. One of the 
rheumatologists from the larger public hospital in the area (Author M. A. B.) referred FMS 
patients in need of psychological treatment to the study. Participants visited the university 
clinical psychology center and were evaluated for the inclusion criteria in a screening session and 
a diagnostic session where they completed the SCID. Participants were given information about 
the study and were asked to sign an informed consent form if they were willing to participate. 
The participants filled out the pretreatment assessment protocol in one assessment session with 
the help of a clinician. Next, using a free software tool named Random Allocation Software 2.0 
(http://random-allocation-software.software.informer.com/2.0), they were randomly allocated to 
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one of the experimental conditions. Participants in the VR treatment condition received the 
treatment program over three weeks. Three weeks after the completion of the treatment they 
were assessed with the posttreatment protocol. Participants in the treatment as usual (TAU) 
condition received the usual care provided in the rheumatology unit which only included visits 
with the rheumatologist and did not involve any psychological intervention. They were assessed 
again after five weeks (posttreatment assessment) and they were then offered CBT treatment in 
our university clinic. 
 
Results 
 
Pretreatment comparisons 
Chi-square tests showed no differences between the groups at pre-test in any of the demographic 
variables: education, marital status and occupation. A student t-test revealed no differences 
between the groups regarding age.  
Student t-tests were conducted to explore possible differences between the experimental 
conditions at pretreatment. There were no statistically significant differences between the groups 
in any of the outcome variables: impact of fibromyalgia (FIQ), depression (BDI-II), pain 
intensity and interference (BPI), quality of life (QLI), and coping strategies measured by the 
CPCI. 
Pre-post comparisons 
We conducted 2x2 repeated measures ANOVAs (being time the with-in subject variable and 
condition the between subject variable) in order to explore the efficacy of the VR intervention. 
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We calculated Cohen d for an estimation of the effect size. In Table 1 the mean, standard 
deviation and Cohen d are displayed for the pre-post comparisons. 
- Table 1 to be inserted here- 
Regarding the primary outcome measure, the impact of fibromyalgia measured by the FIQ, we 
found a time effect F(1, 59) = 23.99, p < 0.001 and a time x group interaction F(1, 59) = 11.37, p 
< 0.01. Participants in the VRAM group reported a significant reduction in the FIQ score 
compared to participants in the TAU condition. The effect size of the pre-post comparison in the 
VRAM group was large. 
Secondary outcome measures were pain intensity and interference, depression, and perceived 
quality of life. 
With regard to pain intensity, no significant time, F(1, 59) = 2.26, p = 0.138, or interaction effect 
F(1, 59) = 0.18, p = 0.675 were found. The same results were found regarding pain interference 
– no time, F(1, 59) = 0.95, p = 0.334, nor interaction effects, F(1, 59) = 2.18; p = 0.145. 
The ANOVA did reveal a significant time effect, F(1, 59) = 4.72, p = 0.034, but not an 
interaction effect, F(1, 59) = 1.64, p = 0.205, regarding depression. 
With regard to perceived quality of life, there was a significant time effect F(1, 59) = 27.03; p < 
0.001, and interaction effect, F(1, 59) = 15.35, p < 0.001. In this case, the analyses revealed a 
higher increase in this measure in the VRAM group compared to the TAU group. The pre-post 
comparison in the VRAM condition obtained a large effect size. 
We were also interested in exploring changes in coping strategies from pretreatment to 
posttreatment.  
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First we explored the illness-focused coping, Guarding, Resting, and Asking for assistance.  A 
significant time effect, F(1, 59) = 15.79, p < 0.001, and a non significant interaction effect, F(1, 
59) = 2.53, p= 0.117, was found for Guarding. Participants in the VRAM condition reported a 
reduction in the use of this coping strategy with a moderate effect size. In the TAU condition 
there was also a reduction but with a small effect size. No time, F(1, 59) = 0.071, p = 0.791, or 
interaction effect, F(1, 59) = 3.46, p = 0.068 was found for Resting. Similar results were 
obtained for Asking for help, no time effect, F(1, 59) = 1.260, p = 0.266, nor interaction effect, 
F(1, 59) = 0.256, p = 0.615. 
As for the wellness-focused coping, regarding Relaxation, there was a time effect, F(1, 59) = 
4.585, p < 0.05, but not an interaction effect, F(1, 59) = 0.832, p = 0.366. With regard to Task 
persistence, there was a significant time effect, F(1, 59) = 13.20, p < 0.01, and a significant 
interaction effect, F(1, 59) = 11.20, p < 0.01, indicating a larger increase in the use of this 
strategy in the VRAM condition (with a large effect size) compared to the TAU condition. 
Similar results were obtained in Exercise, a time effect, F(1, 59) = 6.05, p < 0.02, and an 
interaction effect, F(1, 59) = 6.56, p < 0.02, indicating a larger increase in this strategy in the 
VRAM condition, with a moderate effect size. A significant time effect was found regarding 
Coping self-statements, F(1, 59) = 8.19, p < 0.02, but not an interaction effect, F(1, 59) = 1.633, 
p = 0.206. 
Finally, the neutral coping strategy, Seeking social support did not reveal any time, F(1, 59) = 
0.731, p = 0.396, or interaction effect, F(1, 59) = 3.836, p = 0.055. 
Satisfaction and acceptability 
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In Table 2 the results from the Satisfaction and Acceptability scale are displayed. The mean 
ratings given by the participants were very high. They found the treatment logical and useful. 
Participants in the VRAM condition were highly satisfied with the treatment and they will 
definitely recommend the treatment to a friend. The participants did not find the treatment 
aversive or unpleasant. Finally, regarding the specific VR component, they found it highly useful 
and reported high satisfaction with it. 
- Table 2 to be inserted here- 
 
Discussion  
 
This work reports the results from a small-sized randomized controlled trial evaluating the 
feasibility, acceptability, and preliminary efficacy of a CBT program for FMS, including an 
activity management component supported by VR. We compared a treatment as usual condition 
(TAU) with a treatment condition including VR as an adjunct to the activity management 
component (VRAM). 
The findings suggest that the VR treatment had positive effects in reducing the impact of FMS 
on the life of the participants (measured by the FIQ). The VRAM group also reported a 
significant improvement in perceived quality of life. In these two variables the effect sizes 
(Cohen d) from pretreatment to posttreatment were large. No significant changes were noted 
regarding pain intensity and interference, and depression. Regarding this last variable it is 
important to notice that participants in our sample did not report high levels of depression at 
pretreatment (in fact, none of them met DSM-IV criteria for depressive disorders). This could 
have influenced the lack of significant changes from pretreatment to posttreatment. 
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Significant changes in the use of several coping strategies were found mainly in the wellness-
focused strategies. There were not significant differences between conditions in Guarding, 
Resting and Asking for Assistance, although the most significant effects were found in Guarding 
(medium effect size in the comparison between pretreatment and posttreatment). This strategy 
refers to the extent to which an individual restricts movements as a way of coping with pain. 
Restriction of movements is not recommended in chronic pain management because it increases 
pain, stiffness and other symptoms. It seems that the treatment program, focusing on activity 
activation, helped the participants to understand this fact and to start reducing this unhealthy 
strategy. Important changes occurred regarding wellness-focused strategies (Task persistence and 
Exercise). In this case, significant increments with medium to large effect sizes in the use of 
these two coping strategies were found in the VRAM group. There were no significant 
differences between conditions in the other healthy and neutral strategies (Relaxation, Coping 
self-statements and Seeking social support). The treatment program was focused on activity 
management which involves behaviour activation, restoring discontinued activities, and 
balancing activity with periods of rest. This is achieved by means of meaningful programmed 
activities. The goal is to maintain a healthy level of activity, promoting self-efficacy, and 
decreasing negative affect and avoidance of activities because of pain. Our data support that the 
work done during the treatment in activity management promoted the increase of Exercise 
(physical activity) and Task persistence (extent to which an individual continues normal activity 
despite the pain). Our program did not include other components like cognitive therapy, 
relaxation or communication skills. This could explain the lack of more significant effect in 
Coping self-statements (use of adaptive cognitions to cope with pain), Relaxation, or Seeking 
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social support (frequency in which an individual seeks out a significant other for support when in 
pain). 
Our findings support the importance of the activity management component in the treatment of 
FMS. [29] The treatment program included this component as the main therapeutic ingredient 
but not other psychological components such as cognitive therapy. The reason for doing so was 
that we were interested in exploring the feasibility of integrating VR with this component and 
making a preliminary evaluation of its effect without the influence of other powerful elements 
like formal cognitive therapy. 
Working in this component produced a reduction in disability and an increase in the perceived 
quality of life. Restoring and balancing activity is a challenge in chronic pain and FMS. It is 
difficult for FMS sufferers to set goals related to activities that are meaningful for them and to 
perform those activities in a progressive way. Low mood, fear, pain and fatigue get in the way of 
the willingness to perform the activities, causing low motivation and a poor sense of self-
efficacy. Our goal was to develop a VR environment with contents aimed to promote motivation 
and positive affect in order to support the activity management component. This is in line with 
the ideas reported by Keefe et al. [17] about the advantages of integrating VR with behavioral 
interventions for pain, such as the fact that VR offers the possibility of standardizing the 
presentation of therapeutic instructions. In our case we developed three different VR sessions for 
FMS that were offered in the same way to all participants in the VRAM condition and that could 
be used in the future for other FMS patients. VR is also a useful means for the patient to practice 
in a protected environment in order to be more motivated with practicing the strategies in their 
natural environment. In our case, the idea was to promote motivation and self-efficacy in VR to 
make it more likely and easier for the patients to perform the programmed activities.  
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Innovation in technology and treatment development is a challenge involving several issues. One 
of the most important in the field of VR therapeutic applications is the acceptability of the 
technology. We evaluated this issue by asking patients to rate some questions related to their 
satisfaction with the treatment program and with the VR environments. These data are very 
promising because, although our sample was referred from a public hospital and had a low 
expertise in the use of technology in general, and no experience with the use of VR, they 
reported being very satisfied with the VR intervention. This is in line with other domains where 
VR has been applied. [12] This technology is usually well-accepted by patients with 
psychological disorders. Our data suggest that VR could also be well accepted by chronic pain 
sufferers. These data support the feasibility of incorporating this technology to real clinical 
settings. Also, the hardware and software needed to apply the VRAM component is not costly 
and the logistics is not complicated (two PCs, a 3 x 4 m screen, two projectors and a 7.1 
surround audio system could be installed in a regular room for group therapy). 
Although the results from this study are promising, it has several limitations. The sample size 
was small and this study needs to be performed with larger samples. Another limitation is that 
we did not compare the VRAM condition with an active treatment condition or an attention-
control condition. The reason for this is that this is a preliminary test. The scarce literature in the 
use of VR in FMS and also in chronic pain took us to a less strict design for this first small-sized 
controlled study, with the aim of exploring the feasibility, acceptability and preliminary efficacy 
of VR in this population. Also, we chose the more ecological setting, a rheumatology unit at a 
public hospital where FMS in Spain usually are referred and treated. The disadvantage is that it 
is complicated to conduct a clinical trial in that setting and because of that we included only two 
experimental conditions. FMS sufferers in a public setting in our country are usually middle-age 
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women with a low level of education and low expertise with technology. In our case, 57.4% of 
the sample had eight or less years of education, and only 11.4% had a university degree. We had 
a previous experience using VR with this population in a case series with six participants, [28] 
but we were concerned with the acceptability of the technology by this population. Our data 
support the fact that the VR environment was well accepted by this study’s sample. The next step 
is to conduct a clinical trial comparing the efficacy of a traditional CBT program with a CBT 
program including the VRAM component. 
One more limitation is that the treatment program did not include other powerful psychological 
components usually included in CBT programs for FMS and did not include follow-up 
assessments. The reason for not doing so was that our aim was to explore the preliminary effect 
of the integration of VR in an activity management component. If we had included other 
components like cognitive therapy it would be more difficult to attribute the effect to the activity 
management program. In the future, if the utility of this component is confirmed, we plan to 
include our VR + activity management component in a multicomponent CBT program and test 
its short and long-term efficacy. 
In summary, to our knowledge, this is the first controlled study of a preliminary evaluation of the 
utility, efficacy and acceptability of VR in the field of FMS and chronic pain. The findings are 
promising and indicate the potential of this technology in the treatment of chronic pain. 
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 Table 1. Mean and standard deviation for each variable at pretreatment and posttreatment and 
Cohen d for each comparison. 
 
Variable Condition Pretreatment  
M and SD 
Posttreatment 
M and SD 
Cohen d 
FIQ VRAM 61.59 (19.91) 42.37 (15.68) 1.07 
 TAU 60.57 (21.38) 57.02 (17.49) 0.18 
BDI-II VRAM 19.90 (10.68) 16.55 (8.52) 0.35 
 TAU 20.53 (10.16) 19.67 (9.95) 0.08 
BPI: Intensity VRAM 23.55 (5.07) 22.61 (6.25) 0.17 
 TAU 22.37 (7.97) 20.70 (8.32) 0.21 
BPI: Interference VRAM 32.19 (14.80) 31.23 (17.66) 0.06 
 TAU 32.33 (16.68) 37.07 (12.93) -0.56 
QLI VRAM 4.50 (1.24) 6.10 (1.42) -1.20 
 TAU 5.04 (1.22) 5.26 (1.33) -0.17 
CPCI     
    Guarding VRAM 3.43 (1.36) 2.63 (0.97) 0.68 
 TAU 3.57 (0.96) 3.42 (1.35) 0.13 
    Resting  VRAM 3.77 (1.52) 3.32 (1.35) 0.31 
 TAU 4.00 (1.55) 4.34 (1.30) -0.23 
   Asking for     
   assistance 
VRAM 2.34 (1.33) 2.69 (1.51) -0.25 
TAU 2.79 (1.75) 2.93 (1.65) -0.08 
   Relaxation VRAM 2.22 (1.18) 2.84 (1.45) -0.47 
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TAU 2.28 (1.67) 2.53 (1.67) -0.15 
   Task persistence VRAM 3.74 (1.70) 5.07 (1.32) -0.87 
TAU 3.97 (1.19) 4.03 (1.34) -0.05 
   Exercise VRAM  2.87 (1.46) 3.94 (1.78) -0.65 
TAU 3.17 (1.68) 3.15 (1.77) 0.01 
   Coping self-    
   statements 
VRAM 3.01 (1.51) 3.92 (1.79) -0.55 
TAU 2.97 (1.74) 3.32 (1.53) -0.48 
   Seeking social    
   support 
VRAM 2.48 (1.42) 2.69 (1.46) -0.49 
TAU 2.91 (2.00) 2.54 (1.45) 0.29 
  
Cohen (1988) defines as d = 0.2 are regarded as a “small”’ effect size, d = 0.5 
as “medium,” and d = 0.8 as “large.” 
FIQ: Fibromyalgia Impact Questionnaire; BDI-II: Beck Depression Inventory; 
BPI: Brief Pain Inventory; QLI: the Quality of Life Index; CPCI: Chronic Pain 
Coping Inventory; VRAM: Virtual reality activity management; TAU: 
Treatment as usual. 
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Table 2. Mean and standard deviation of the ratings given by the patients regarding their 
satisfaction with the treatment program and with the use of VR at posttreatment. 
 
   
 Satisfaction and Acceptability Questionnaire M (DT) 
How logical did the treatment seem to you? 8.45 (1.52) 
How satisfied are you with the treatment? 8.83 (1.39) 
To what extent would you recommend this treatment to a friend? 9.07 (1,13) 
How useful was this treatment for you? 9.00 (1,10) 
How unpleasant was the treatment for you? 0.86 (2,35) 
How satisfied are you with the VR component? 9.00 (1,08) 
How useful was the VR component to you? 9.08 (0.98) 
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Figure 1. Study Flow diagram 
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 1: Drop-out 
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